MELBOURNE, Australia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ( PPCB ) (“Propanc” or the “Company”), a biopharmaceutical company developing new treatments for patients suffering from recurrent and metastatic cancer, today announced a strategic initiative to pursue the acquisition of Digital Asset Treasury (DAT) companies that are currently trading below their Market Cap to Net Asset Value (MNAV)....

Overview * PJT Partners ( PJT ) Q3 revenue grows 37% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong financial performance * Company repurchased 2.3 mln shares, indicating confidence in future growth Result Drivers * STRATEGIC ADVISORY - Increase in strategic advisory revenues drove higher Q3 revenue * FUND PLACEMENT - Increase in fund placement...

06:58 AM EST, 11/04/2025 (MT Newswires) -- Molson Coors Beverage ( TAP/A ) reported Q3 non-GAAP earnings Tuesday of $1.67 per diluted share, up/down from $1.80 a year earlier. Analysts polled by FactSet expected $1.69. Net sales for the quarter ended Sept. 30 were $2.97 billion, down from $3.04 billion a year earlier. Analysts surveyed by FactSet expected $3.01 billion....

06:58 AM EST, 11/04/2025 (MT Newswires) -- Pfizer ( PFE ) reported Q3 adjusted earnings Tuesday of $0.87 per diluted share, down from $1.06 a year earlier. Analysts polled by FactSet expected $0.63. Revenue for the quarter was $16.65 billion, compared with $17.70 billion a year earlier. Analysts surveyed by FactSet expected $16.5 billion. The company said it now expects...